We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$739M
Cap. Flow %
-13.15%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$44.1M
2
HRMY icon
Harmony Biosciences
HRMY
+$36.9M
3
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
4
MDLN
Medline Inc
MDLN
+$22.4M
5
META icon
Meta Platforms (Facebook)
META
+$20.9M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.19%
2 Healthcare 38.27%
3 Technology 7.29%
4 Consumer Discretionary 4.25%
5 Communication Services 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTAI icon
151
BioXcel Therapeutics
BTAI
$5.68M
$2.56M 0.05%
+1,910,076
New +$3.15M
H icon
152
Hyatt Hotels
H
$16.2B
$2.47M 0.04%
17,175
-10,358
-38% -$1.64M
NTRP icon
153
NextTrip
NTRP
$23.7M
$2.19M 0.04%
675,117
-324,883
-32% -$985K
ARAY icon
154
Accuray
ARAY
$32.7M
$2.19M 0.04%
5,636,000
+1,136,000
+25% +$702K
CNDT icon
155
Conduent
CNDT
$267M
$2.09M 0.04%
1,636,000
+58,000
+4% +$88.4K
WWW icon
156
Wolverine World Wide
WWW
$1.67B
$2.04M 0.04%
125,000
-160,000
-56% -$2.82M
REED
157
Reed's Inc
REED
$11.3M
$1.99M 0.04%
548,995
-71,005
-11% -$192K
SCLX icon
158
Scilex Holding
SCLX
$38.2M
$1.98M 0.04%
297,706
-178,968
-38% -$1.64M
ABNB icon
159
Airbnb
ABNB
$112B
$1.92M 0.03%
15,190
-5,502
-27% -$716K
QTEX
160
QTREX Quantum
QTEX
$55.9M
$1.85M 0.03%
+4,139,086
New +$2.8M
PRSU
161
Pursuit Attractions and Hospitality Inc
PRSU
$1.36B
$1.74M 0.03%
47,500
– –
VVOS icon
162
Vivos Therapeutics
VVOS
$4.52M
$1.32M 0.02%
+1,115,859
New +$1.79M
GEV icon
163
GE Vernova
GEV
$243B
$1.28M 0.02%
+1,461
New +$1.14M
IMNN icon
164
Imunon
IMNN
$8.98M
$1.02M 0.02%
348,330
+81,444
+31% +$268K
TRX icon
165
TRX Gold Corp
TRX
$377M
$945K 0.02%
+630,174
New +$930K
VSEE
166
DELISTED
VSEE HEALTH INC
VSEE
$875K 0.02%
+3,498,227
New +$1.19M
OTLK icon
167
Outlook Therapeutics
OTLK
$156M
$858K 0.02%
+4,168,000
New +$1.8M
ICCM icon
168
IceCure Medical
ICCM
$7.88M
$816K 0.01%
+90,400
New +$1.65M
XLE icon
169
State Street Energy Select Sector SPDR ETF
XLE
$41.2B
$803K 0.01%
+13,114
New +$703K
ANF icon
170
Abercrombie & Fitch
ANF
$6.59B
$777K 0.01%
8,501
+1,857
+28% +$181K
BCTXL
171
BriaCell Therapeutics Warrant
BCTXL
$2.67M
$553K 0.01%
+536,600
New +$568K
KVUE icon
172
Kenvue
KVUE
$36.8B
$510K 0.01%
29,604
-3,962,592
-99% -$70.6M
XOP icon
173
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.78B
$497K 0.01%
+2,733
New +$412K
MS icon
174
Morgan Stanley
MS
$337B
$497K 0.01%
+3,017
New +$522K
RITM icon
175
Rithm Capital
RITM
$5.63B
$464K 0.01%
+48,987
New +$513K
5 6
7
8 9

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $739M in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, down from 51% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.